CIK 0001739104
- Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825497352
- Phone
- +1 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $935,920
- in 1 filing
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$835,870. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-22 | Kinard David S See Remarks | Grant or award | +22,598 | 97,976 | ||
| 2022-02-22 | Kinard David S See Remarks | Shares withheld for taxes | −9,400 | $25.98 | $244K | 88,576 |
| 2022-02-22 | Simmons Jeffrey N President, CEO and Director | Grant or award | +229,655 | 782,418 | ||
| 2022-02-22 | Simmons Jeffrey N President, CEO and Director | Shares withheld for taxes | −92,948 | $25.98 | $2.4M | 689,470 |
| 2022-02-22 | Urbanek David Alan See Remarks | Grant or award | +24,841 | 95,083 | ||
| 2022-02-22 | Urbanek David Alan See Remarks | Shares withheld for taxes | −10,305 | $25.98 | $268K | 84,778 |
| 2022-02-22 | YOUNG TODD S. See Remarks | Grant or award | +55,205 | 126,705 | ||
| 2022-02-22 | YOUNG TODD S. See Remarks | Shares withheld for taxes | −22,557 | $25.98 | $586K | 104,148 |
| 2022-01-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +409.63 | $26.04 | $11K | 20,019.88 |
| 2022-01-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +352.02 | $26.04 | $9K | 9,370.31 |
| 2022-01-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +339.22 | $26.04 | $9K | 8,855.62 |
| 2022-01-03 | Meer James M CHIEF ACCOUNTING OFFICER | Grant or award | +3,540 | 14,607 | ||
| 2021-12-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +751.7 | $28.38 | $21K | 19,610.25 |
| 2021-12-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +323 | $28.38 | $9K | 9,018.29 |
| 2021-12-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +311.25 | $28.38 | $9K | 8,516.4 |
| 2021-12-31 | Anand Kapila K Director | Grant or award · Deferred Stock Units | +168.84 | $28.38 | $5K | 1,458.08 |
| 2021-11-30 | Ferguson Scott D. Director | Grant or award | +7,307 | 7,307 | ||
| 2021-11-30 | HOOVER R DAVID Director | Purchase | +10,000 | $29.38 | $294K | 105,000 |
| 2021-11-30 | HOOVER R DAVID Director | Grant or award | +7,307 | 39,267 | ||
| 2021-11-30 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +742.29 | $28.74 | $21K | 18,858.55 |
Page 32 of 35 · 697 trades